Surgeon's Record March 11, 2025
Musculoskeletal care is often cited as a microcosm of healthcare’s systemic dysfunction — low-value treatments, misaligned incentives, spiraling costs, and highly variable quality. My specialty is fraught with opacity, inefficiency, and information asymmetry, which makes it difficult for patients, primary care providers, employers, and health plans to identify and access high-value MSK treatment.
The problem is big and growing.
For this week’s edition of The Surgeon’s Record, I’m revisiting a post I wrote last year — “Case Study in MSK Value: Cascading Failure”—that highlighted these issues through a fictional patient journey. As I head to the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Diego this week (where I’ll be moderating a session on...
Today's Sponsors
Today's Sponsor